Early Detection of Chronic Kidney Disease: Results of the PolNef Study

Background: Continuous increase in the number of patients with end-stage renal disease demands early detection of chronic kidney disease (CKD). The aim of the present study was to diagnose CKD in its earliest stages in a randomly selected population using a diagnostic algorithm developed by the working group. Methods: An algorithm for the diagnostic procedure was created to identify patients with CKD requiring further nephrological care. Randomly chosen adult inhabitants of a city with a population of 60,000 were invited to participate in this study. Screening procedures included a microalbuminuria dipstick test accompanied by blood pressure measurement and medical questionnaire. In further diagnosis of CKD, estimated glomerular filtration rate (eGFR), albumin concentration in urine, urinalysis and ultrasound examination were used according to the algorithm. Multivariate logistic regression was performed to identify associations between participants’ characteristics and albuminuria. Results: Out of 9,700 invited subjects, 2,471 individuals participated in the PolNef study. Albuminuria was detected in 15.6% of the investigated population using the dipstick test and thereafter confirmed in 11.9% by the turbidimetric method. The modeling of multivariate logistic regression indicated the following independent predictors of albuminuria: male sex, diabetes, nocturia and hypertension. For people without diabetes and without hypertension, nocturia independently predicted detection of albuminuria. 481 people received a consultation with a nephrologist, and 96% of them were recognized as having CKD. At least 9% of patients with CKD had eGFR by MDRD <60 ml/min/1.73 m2. Six persons were referred for further treatment because of newly diagnosed kidney tumor. Conclusions: CKD in early stages occurs frequently in the studied population. The proposed diagnostic algorithm seems to be a powerful tool to identify subjects at risk of CKD. The role of nocturia as an independent predictor of albuminuria, both in the general population and in people without diabetes or hypertension, should be further examined.

[1]  J. Diaz Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals , 2002 .

[2]  Giuseppe Remuzzi,et al.  Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. , 2005, Kidney international. Supplement.

[3]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Homer W. Smith Nephron adaptation to renal injury or ablation , 2003 .

[5]  D. de Zeeuw,et al.  Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  W. McClellan,et al.  Taking a public health approach to the prevention of end-stage renal disease: the NKF Singapore Program. , 2003, Kidney international. Supplement.

[7]  G. Striker,et al.  Structural-functional correlations in renal disease , 1970 .

[8]  M. Kubo,et al.  Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. , 2005, Kidney international.

[9]  R. Gansevoort,et al.  Screening techniques for detecting chronic kidney disease , 2005, Current opinion in nephrology and hypertension.

[10]  P. Elliott,et al.  Evaluation of measures of urinary albumin excretion in epidemiologic studies. , 2004, American journal of epidemiology.

[11]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[12]  G. Maguire,et al.  Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[14]  M. Nieminen,et al.  Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.

[15]  T A Louis,et al.  Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. , 2001, Journal of the American Society of Nephrology : JASN.

[16]  J. Burgerhof,et al.  The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. , 2005, Kidney international. Supplement.

[17]  James D Neaton,et al.  Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  A. Collins,et al.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015. , 2005, Journal of the American Society of Nephrology : JASN.

[19]  B. Rutkowski,et al.  Changing pattern of end-stage renal disease in central and eastern Europe. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  M. Klag,et al.  Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  I. Kubota,et al.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. , 2006, Kidney international.

[22]  J. Shaw,et al.  Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  N. Powe,et al.  Principles of screening for chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[24]  S. Romundstad,et al.  Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  D. de Zeeuw,et al.  An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. , 2004, Kidney international. Supplement.

[27]  A. Garg,et al.  Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. , 2003, Kidney international.

[28]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.

[29]  A. Bello,et al.  Chronic kidney disease: the global challenge , 2005, The Lancet.

[30]  A. Bello,et al.  Prevention of chronic kidney disease: a global challenge. , 2005, Kidney international. Supplement.

[31]  J. Maccluer,et al.  A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  N. Wareham,et al.  What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? , 2005, Current opinion in nephrology and hypertension.

[34]  D. de Zeeuw,et al.  The kidney, a cardiovascular risk marker, and a new target for therapy. , 2005, Kidney international. Supplement.

[35]  J. Shaw,et al.  Prevalence of albuminuria in Australia: the AusDiab Kidney Study. , 2004, Kidney international. Supplement.

[36]  B. Rutkowski Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  A. Eddy Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. , 1994, Journal of the American Society of Nephrology : JASN.